Literature DB >> 16966437

Collectins and cationic antimicrobial peptides of the respiratory epithelia.

B Grubor1, D K Meyerholz, M R Ackermann.   

Abstract

The respiratory epithelium is a primary site for the deposition of microorganisms that are acquired during inspiration. The innate immune system of the respiratory tract eliminates many of these potentially harmful agents preventing their colonization. Collectins and cationic antimicrobial peptides are antimicrobial components of the pulmonary innate immune system produced by respiratory epithelia, which have integral roles in host defense and inflammation in the lung. Synthesis and secretion of these molecules are regulated by the developmental stage, hormones, as well as many growth and immunoregulatory factors. The purpose of this review is to discuss antimicrobial innate immune elements within the respiratory tract of healthy and pneumonic lung with emphasis on hydrophilic surfactant proteins and beta-defensins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966437      PMCID: PMC2786072          DOI: 10.1354/vp.43-5-595

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  153 in total

Review 1.  Diversity of antimicrobial peptides and their mechanisms of action.

Authors:  R M Epand; H J Vogel
Journal:  Biochim Biophys Acta       Date:  1999-12-15

Review 2.  Collectins and pulmonary innate immunity.

Authors:  E Crouch; K Hartshorn; I Ofek
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 3.  The innate immune response of the respiratory epithelium.

Authors:  G Diamond; D Legarda; L K Ryan
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 4.  The role of antimicrobial peptides in animal defenses.

Authors:  R E Hancock; M G Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia.

Authors:  J Harder; U Meyer-Hoffert; L M Teran; L Schwichtenberg; J Bartels; S Maune; J M Schröder
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

6.  Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.

Authors:  S van Wetering; A C van der Linden; M A van Sterkenburg; W I de Boer; A L Kuijpers; J Schalkwijk; P S Hiemstra
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

7.  Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein.

Authors:  M G Scott; A C Vreugdenhil; W A Buurman; R E Hancock; M R Gold
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

8.  African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.

Authors:  A P Durbin; W R Elkins; B R Murphy
Journal:  Vaccine       Date:  2000-05-08       Impact factor: 3.641

Review 9.  Innate immunity and the normal microflora.

Authors:  H G Boman
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

10.  Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs.

Authors:  R C Tan; M Ikegami; A H Jobe; L Y Yao; F Possmayer; P L Ballard
Journal:  Am J Physiol       Date:  1999-12
View more
  17 in total

1.  Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung.

Authors:  David K Meyerholz; James A DeGraaff; Jack M Gallup; Alicia K Olivier; Mark R Ackermann
Journal:  J Histochem Cytochem       Date:  2006-08-09       Impact factor: 2.479

2.  Ontogeny of the immune response in the ovine lung.

Authors:  Fatoumata B Sow; Jack M Gallup; Rachel Derscheid; Subramaniam Krishnan; Mark R Ackermann
Journal:  Immunol Invest       Date:  2011-11-28       Impact factor: 3.657

3.  Effects of nicotine on pulmonary surfactant proteins A and D in ovine lung epithelia.

Authors:  Tatjana Lazic; Milan Matic; Jack M Gallup; Albert Van Geelen; David K Meyerholz; Branka Grubor; Paula M Imerman; Marcia M M A de-Macedo; Mark R Ackermann
Journal:  Pediatr Pulmonol       Date:  2010-03

Review 4.  Innate immunology of bovine respiratory disease.

Authors:  Mark R Ackermann; Rachel Derscheid; James A Roth
Journal:  Vet Clin North Am Food Anim Pract       Date:  2010-05-14       Impact factor: 3.357

5.  Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia.

Authors:  Tatjana Lazic; Todd A Wyatt; Milan Matic; David K Meyerholz; Branka Grubor; Jack M Gallup; Karl W Kersting; Paula M Imerman; Marcia Almeida-De-Macedo; Mark R Ackermann
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

Review 6.  Lessons learned from the cystic fibrosis pig.

Authors:  David K Meyerholz
Journal:  Theriogenology       Date:  2016-04-21       Impact factor: 2.740

7.  Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of respiratory syncytial virus infection.

Authors:  David K Meyerholz; Jack M Gallup; Tatjana Lazic; Marcia M A de Macedo; Howard D Lehmkuhl; Mark R Ackermann
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

Review 8.  Investigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infection.

Authors:  Mary Leissinger; Ritwij Kulkarni; Rachel L Zemans; Gregory P Downey; Samithamby Jeyaseelan
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

Review 9.  Bacterial Stress Responses during Host Infection.

Authors:  Ferric C Fang; Elaine R Frawley; Timothy Tapscott; Andrés Vázquez-Torres
Journal:  Cell Host Microbe       Date:  2016-08-10       Impact factor: 21.023

Review 10.  The potential of antimicrobial peptides as biocides.

Authors:  Garry Laverty; Sean P Gorman; Brendan F Gilmore
Journal:  Int J Mol Sci       Date:  2011-10-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.